Shares of Health Care sector company Ionis Pharmaceuticals moved 1.7% today, and are now trading at a price of $36.76. The Mid-Cap stock's daily volume was 81,295 compared to its average volume of 1,652,457. The S&P 500 index returned a 0.0% performance.
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company is based in Carlsbad and has 1,069 full time employees. Its market capitalization is $5,850,684,928.
26 analysts are following Ionis Pharmaceuticals and have set target prices ranging from $37.0 to $83.0 per share. On average, they have given the company a rating of buy. At today's prices, IONS is trading -36.24% away from its average analyst target price of $57.66 per share.
Over the last year, IONS shares have gone down by -11.4%, which represents a difference of -20.7% when compared to the S&P 500. The stock's 52 week high is $52.34 per share and its 52 week low is $23.95. Ionis Pharmaceuticals has averaged free cash flows of $-138883000.0 over the last 5 years, with a mean growth rate of -17.2%. It is likely that the stock will keep following its current negative performance trend while the underlying business is experiencing such poor cash flows.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | -500,947 | 45,280 | -546,227 | -64.86 |
| 2023 | -307,513 | 23,805 | -331,318 | -14.21 |
| 2022 | -274,370 | 15,721 | -290,091 | -1639.43 |
| 2021 | 30,799 | 11,955 | 18,844 | 2340.93 |
| 2020 | 35,892 | 35,120 | 772 | -99.75 |
| 2019 | 345,627 | 30,905 | 314,722 |
